Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Stoke Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 97 | 100 | +3 |
| Shares | 44.5M | 46.5M | +2.01M (+4.5%) |
| Value | $371.8M | $494.8M | +$122.9M (+33.1%) |
New holders (12)
Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Driehaus Capital Management LLC | 102,489 | $1.09M | 0.01% |
| Ikarian Capital, LLC | 70,390 | $748.2K | 0.26% |
| Schonfeld Strategic Advisors LLC | 62,902 | $668.6K | 0.01% |
| Simplex Trading, LLC | 50,555 | $537.0K | 0.02% |
| Norges Bank | 24,700 | $262.6K | 0.00% |
| Belvedere Trading LLC | 15,783 | $167.8K | 0.05% |
| Boothbay Fund Management, LLC | 14,180 | $150.7K | 0.01% |
| Credit Suisse AG | 13,511 | $143.6K | 0.00% |
| Franklin Resources Inc | 12,643 | $134.4K | 0.00% |
| Principal Financial Group Inc | 11,388 | $121.1K | 0.00% |
| Voya Investment Management LLC | 11,175 | $118.8K | 0.00% |
| EverSource Wealth Advisors, LLC | 127 | $1.35K | 0.00% |
Sold out (9)
Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| HRT Financial LP | 69,440 | $578.0K |
| Jane Street Group, LLC | 33,487 | $278.9K |
| Cubist Systematic Strategies, LLC | 28,876 | $240.5K |
| Squarepoint Ops LLC | 17,851 | $148.7K |
| Ergoteles LLC | 16,871 | $140.5K |
| State Board of Administration of Florida Retirement System | 10,473 | $87.2K |
| Point72 Asset Management, L.P. | 9,409 | $78.4K |
| Group One Trading, L.P. | 236 | $1.97K |
| Investors Research Corp | 50 | $417 |